Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH – Get Free Report)’s share price fell 0.7% on Wednesday . The company traded as low as $0.61 and last traded at $0.61. 40,294 shares were traded during mid-day trading, a decline of 91% from the average session volume of 433,445 shares. The stock had previously closed at $0.62.
Shuttle Pharmaceuticals Trading Down 0.7 %
The stock has a 50-day moving average of $1.07. The company has a market cap of $2.24 million, a PE ratio of -0.15 and a beta of -1.70.
About Shuttle Pharmaceuticals
Shuttle Pharmaceuticals Holdings, Inc, a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers .
Featured Stories
- Five stocks we like better than Shuttle Pharmaceuticals
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- What is the Hang Seng index?
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- When to Sell a Stock for Profit or Loss
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for Shuttle Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shuttle Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
